DR. ALAN L SCHWARTZ, MD
Medical Practice at Childrens Pl, Saint Louis, MO
License number
Missouri R8F18
Category
Medical Practice
Type
Pediatric Hematology-Oncology
Address
Address
1 Childrens Pl, Saint Louis, MO 63110
Phone
(314) 454-6018
(314) 454-2780 (Fax)
(314) 454-2780 (Fax)
Professional information
See more information about ALAN L SCHWARTZ at trustoria.com
Alan Leigh Schwartz, Saint Louis MO
Alan Leigh Schwartz, Saint Louis MO
Specialties:
Pediatrics, Pediatric Hematology-Oncology, Hematology, Medical Oncology
Work:
Div of Hematology/Oncology
1 Childrens Pl, Saint Louis, MO 63110
1 Childrens Pl, Saint Louis, MO 63110
Education:
Case Western Reserve University(1976)
Methods And Compositions For Inhibition Of Hepatic Clearance Of Tissue-Type Plasminogen Activator
Methods And Compositions For Inhibition Of Hepatic Clearance Of Tissue-Type Plasminogen Activator
US Patent:
5474766, Dec 12, 1995
Filed:
Dec 18, 1992
Appl. No.:
7/992827
Inventors:
Alan L. Schwartz - Clayton MO
Guojun Bu - Chesterfield MO
Guojun Bu - Chesterfield MO
Assignee:
Washington University - St. Louis MO
International Classification:
A61K 3816, A61K 3849, C07K 1447
US Classification:
424 9464
Abstract:
Methods and compositions for inhibiting the hepatic clearance of tissue-type plasminogen activator (t-PA) in vivo by administering a t-PA-hepatic clearance-inhibiting amount of 39 kDa protein or a t-PA-hepatic clearance-inhibiting fragment thereof, or genetically or chemically modified forms of the 39 kDa protein or fragments thereof are described. Methods and compositions for treatment of thrombolytic diseases by administering t-PA and a t-PA-hepatic clearance-inhibiting effective amount of 39 kDa protein, a t-PA-hepatic clearance inhibiting fragment thereof, and genetically or chemically modified forms of the 39 kDa protein or its fragments are described.
Methods And Compositions For Inhibition Of Hepatic Clearance Of Tissue Factor Pathway Inhibitor
Methods And Compositions For Inhibition Of Hepatic Clearance Of Tissue Factor Pathway Inhibitor
US Patent:
5650391, Jul 22, 1997
Filed:
Mar 21, 1994
Appl. No.:
8/216593
Inventors:
Alan L. Schwartz - Clayton MO
Ilka Warshawsky - St. Louis MO
George J. Broze - Ladue MO
Ilka Warshawsky - St. Louis MO
George J. Broze - Ladue MO
Assignee:
Jewish Hospital of St. Louis - St. Louis MO
International Classification:
A61K 3816
US Classification:
514 12
Abstract:
The present invention discloses methods and compositions for inhibiting the hepatic clearance of Tissue Factor Pathway Inhibitor (TFPI) using receptor-associated protein.